{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T04:12:54Z","timestamp":1740111174841,"version":"3.37.3"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003052","name":"Ministry of Trade, Industry and Energy","doi-asserted-by":"publisher","award":["20016417"],"id":[{"id":"10.13039\/501100003052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003662","name":"Korea Evaluation Institute of Industrial Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003662","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006107","name":"Gil Medical Center, Gachon University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006107","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computers in Biology and Medicine"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.compbiomed.2023.106602","type":"journal-article","created":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T07:00:27Z","timestamp":1674543627000},"page":"106602","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Oncogenic signaling pathways and hallmarks of cancer in Korean patients with acral melanoma"],"prefix":"10.1016","volume":"154","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3786-5342","authenticated-orcid":false,"given":"SeongRyeol","family":"Moon","sequence":"first","affiliation":[]},{"given":"Hee Joo","family":"Kim","sequence":"additional","affiliation":[]},{"given":"Yeeun","family":"Lee","sequence":"additional","affiliation":[]},{"given":"Yu Joo","family":"Lee","sequence":"additional","affiliation":[]},{"given":"Sungwon","family":"Jung","sequence":"additional","affiliation":[]},{"given":"Jin Sook","family":"Lee","sequence":"additional","affiliation":[]},{"given":"Si Houn","family":"Hahn","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9426-8304","authenticated-orcid":false,"given":"Kyungdoc","family":"Kim","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9878-6691","authenticated-orcid":false,"given":"Joo Young","family":"Roh","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0966-7915","authenticated-orcid":false,"given":"Seungyoon","family":"Nam","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/j.compbiomed.2023.106602_bib1","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1101\/gr.213348.116","article-title":"Integrated genomic analyses reveal frequent TERT aberrations in acral melanoma","volume":"27","author":"Liang","year":"2017","journal-title":"Genome Res."},{"key":"10.1016\/j.compbiomed.2023.106602_bib2","doi-asserted-by":"crossref","first-page":"5259","DOI":"10.1038\/s41467-020-18988-3","article-title":"Whole-genome sequencing of acral melanoma reveals genomic complexity and diversity","volume":"11","author":"Newell","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.compbiomed.2023.106602_bib3","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/00008390-200412000-00016","article-title":"Malignant melanoma in Taiwan: a prognostic study of 181 cases","volume":"14","author":"Chang","year":"2004","journal-title":"Melanoma Res."},{"key":"10.1016\/j.compbiomed.2023.106602_bib4","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","article-title":"Genomic classification of cutaneous melanoma","volume":"161","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.compbiomed.2023.106602_bib5","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nature22071","article-title":"Whole-genome landscapes of major melanoma subtypes","volume":"545","author":"Hayward","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.compbiomed.2023.106602_bib6","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jid.2017.11.017","article-title":"Genetic alterations in primary acral melanoma and acral melanocytic nevus in Korea: common mutated genes show distinct cytomorphological features","volume":"138","author":"Moon","year":"2018","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.compbiomed.2023.106602_bib7","first-page":"S0190","article-title":"Distinct genomic features in a retrospective cohort of mucosal, acral and vulvovaginal melanomas","author":"Shi","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.compbiomed.2023.106602_bib8","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.18632\/oncotarget.27642","article-title":"Mutation profile of primary subungual melanomas in Caucasians","volume":"11","author":"Borkowska","year":"2020","journal-title":"Oncotarget"},{"key":"10.1016\/j.compbiomed.2023.106602_bib9","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.3390\/ijms22083826","article-title":"The molecular landscape of primary acral melanoma: a multicenter study of the Italian melanoma intergroup (imi)","volume":"22","author":"Elefanti","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.compbiomed.2023.106602_bib10","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jaad.2018.02.019","article-title":"Whole-exome sequencing reveals differences between nail apparatus melanoma and acral melanoma","volume":"79","author":"Lee","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.compbiomed.2023.106602_bib11","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/j.jaad.2020.03.109","article-title":"Novel mutations identified by whole-exome sequencing in acral melanoma","volume":"83","author":"Lim","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.compbiomed.2023.106602_bib12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.21873\/cgp.20243","article-title":"Genomic landscapes of acral melanomas in east asia","volume":"18","author":"Chang","year":"2021","journal-title":"Cancer Genomics Proteomics"},{"key":"10.1016\/j.compbiomed.2023.106602_bib13","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/1346-8138.15841","article-title":"Identification of genetic mutations related to invasion and metastasis of acral melanoma via whole-exome sequencing","volume":"48","author":"Lim","year":"2021","journal-title":"J. Dermatol."},{"key":"10.1016\/j.compbiomed.2023.106602_bib14","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.cell.2018.03.035","article-title":"Oncogenic signaling pathways in the cancer genome Atlas","volume":"173","author":"Sanchez-Vega","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.compbiomed.2023.106602_bib15","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.compbiomed.2023.106602_bib16","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1093\/bioinformatics\/btac177","article-title":"A comprehensive evaluation of regression-based drug responsiveness prediction models, using cell viability inhibitory concentrations (IC50 values)","volume":"38","author":"Park","year":"2022","journal-title":"Bioinformatics"},{"key":"10.1016\/j.compbiomed.2023.106602_bib17","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s11864-022-01007-6","article-title":"Advanced Acral Melanoma Therapies: Current Status and Future Directions","volume":"23","author":"Zhang","year":"2022","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.compbiomed.2023.106602_bib18","doi-asserted-by":"crossref","first-page":"bbac100","DOI":"10.1093\/bib\/bbac100","article-title":"DeepTTA: a transformer-based model for predicting cancer drug response","volume":"23","author":"Jiang","year":"2022","journal-title":"Briefings Bioinf"},{"key":"10.1016\/j.compbiomed.2023.106602_bib19","doi-asserted-by":"crossref","first-page":"8857","DOI":"10.1038\/s41598-018-27214-6","article-title":"Cancer drug response profile scan (CDRscan): a deep learning model that predicts drug effectiveness from cancer genomic signature","volume":"8","author":"Chang","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.compbiomed.2023.106602_bib20","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1101\/gr.107524.110","article-title":"The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data","volume":"20","author":"McKenna","year":"2010","journal-title":"Genome Res."},{"key":"10.1016\/j.compbiomed.2023.106602_bib21","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1093\/nar\/gkq603","article-title":"ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2023.106602_bib22","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s40425-019-0647-4","article-title":"Tumor mutational burden quantification from targeted gene panels: major advancements and challenges","volume":"7","author":"Fancello","year":"2019","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.compbiomed.2023.106602_bib23","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/bioinformatics\/btt017","article-title":"CRAVAT: cancer-related analysis of variants toolkit","volume":"29","author":"Douville","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.compbiomed.2023.106602_bib24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.compbiomed.2023.106602_bib25","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/1471-2105-12-323","article-title":"RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome","volume":"12","author":"Li","year":"2011","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.compbiomed.2023.106602_bib26","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.cell.2018.03.022","article-title":"Cell-of-Origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer","volume":"173","author":"Hoadley","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.compbiomed.2023.106602_bib27","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","article-title":"Visualizing and interpreting cancer genomics data via the Xena platform","volume":"38","author":"Goldman","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.compbiomed.2023.106602_bib28","doi-asserted-by":"crossref","first-page":"W102","DOI":"10.1093\/nar\/gky406","article-title":"Mutalisk: a web-based somatic MUTation AnaLyIS toolKit for genomic, transcriptional and epigenomic signatures","volume":"46","author":"Lee","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2023.106602_bib29","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","article-title":"The repertoire of mutational signatures in human cancer","volume":"578","author":"Alexandrov","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.compbiomed.2023.106602_bib30","doi-asserted-by":"crossref","first-page":"D941","DOI":"10.1093\/nar\/gky1015","article-title":"COSMIC: the catalogue of somatic mutations in cancer","volume":"47","author":"Tate","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2023.106602_bib31","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/nbt.3344","article-title":"Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes","volume":"33","author":"Shukla","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.compbiomed.2023.106602_bib32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13073-016-0264-5","article-title":"pVAC-Seq: a genome-guided in silico approach to identifying tumor neoantigens","volume":"8","author":"Hundal","year":"2016","journal-title":"Genome Med."},{"key":"10.1016\/j.compbiomed.2023.106602_bib33","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.1093\/bioinformatics\/btz193","article-title":"ScanNeo: identifying indel-derived neoantigens using RNA-Seq data","volume":"35","author":"Wang","year":"2019","journal-title":"Bioinformatics"},{"key":"10.1016\/j.compbiomed.2023.106602_bib34","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1101\/gr.129684.111","article-title":"VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing","volume":"22","author":"Koboldt","year":"2012","journal-title":"Genome Res."},{"key":"10.1016\/j.compbiomed.2023.106602_bib35","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/ng0506-500","article-title":"GenePattern 2.0","volume":"38","author":"Reich","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.compbiomed.2023.106602_bib36","doi-asserted-by":"crossref","first-page":"R41","DOI":"10.1186\/gb-2011-12-4-r41","article-title":"GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers","volume":"12","author":"Mermel","year":"2011","journal-title":"Genome Biol."},{"key":"10.1016\/j.compbiomed.2023.106602_bib37","doi-asserted-by":"crossref","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2023.106602_bib38","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11003","article-title":"The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity","volume":"483","author":"Barretina","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.compbiomed.2023.106602_bib39","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1002\/jcc.21707","article-title":"PaDEL-descriptor: an open source software to calculate molecular descriptors and fingerprints","volume":"32","author":"Yap","year":"2011","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.compbiomed.2023.106602_bib40","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal."},{"key":"10.1016\/j.compbiomed.2023.106602_bib41","series-title":"Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining","first-page":"1135","article-title":"Why should i trust you?\" Explaining the predictions of any classifier","author":"Ribeiro","year":"2016"},{"key":"10.1016\/j.compbiomed.2023.106602_bib42","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1158\/1535-7163.MCT-09-0459","article-title":"Activity of dasatinib against L576P KIT mutant melanoma: molecular, cellular, and clinical correlates","volume":"8","author":"Woodman","year":"2009","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.compbiomed.2023.106602_bib43","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1158\/1541-7786.MCR-08-0021","article-title":"Loss-of-function fibroblast growth factor receptor-2 mutations in melanoma","volume":"7","author":"Gartside","year":"2009","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.compbiomed.2023.106602_bib44","doi-asserted-by":"crossref","first-page":"53869","DOI":"10.18632\/oncotarget.10861","article-title":"c-CBL regulates melanoma proliferation, migration, invasion and the FAK-SRC-GRB2 nexus","volume":"7","author":"Nihal","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.compbiomed.2023.106602_bib45","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/ng.955","article-title":"Mutations in BRIP1 confer high risk of ovarian cancer","volume":"43","author":"Rafnar","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.compbiomed.2023.106602_bib46","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nature11071","article-title":"Melanoma genome sequencing reveals frequent PREX2 mutations","volume":"485","author":"Berger","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.compbiomed.2023.106602_bib47","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.cell.2012.06.024","article-title":"A landscape of driver mutations in melanoma","volume":"150","author":"Hodis","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.compbiomed.2023.106602_bib48","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.compbiomed.2023.106602_bib49","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cell.2016.06.017","article-title":"A landscape of pharmacogenomic interactions in cancer","volume":"166","author":"Iorio","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.compbiomed.2023.106602_bib50","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1126\/science.aaa1348","article-title":"Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer","volume":"348","author":"Rizvi","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.compbiomed.2023.106602_bib51","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s10020-019-0098-x","article-title":"Active repurposing of drug candidates for melanoma based on GWAS, PheWAS and a wide range of omics data","volume":"25","author":"Khosravi","year":"2019","journal-title":"Mol. Med."},{"key":"10.1016\/j.compbiomed.2023.106602_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0219774","article-title":"Predicting drug activity against cancer cells by random forest models based on minimal genomic information and chemical properties","volume":"14","author":"Lind","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.compbiomed.2023.106602_bib53","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1038\/s41375-019-0504-y","article-title":"Elevated expression of S100A8 and S100A9 correlates with resistance to the BCL-2 inhibitor venetoclax in AML","volume":"33","author":"Karjalainen","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.compbiomed.2023.106602_bib54","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jdermsci.2013.07.013","article-title":"BRAF and PTEN mutations in a sample of Swedish patients with acral lentiginous melanoma","volume":"72","author":"Zebary","year":"2013","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.compbiomed.2023.106602_bib55","doi-asserted-by":"crossref","first-page":"6946","DOI":"10.1158\/1078-0432.CCR-17-0070","article-title":"Frequent genetic aberrations in the CDK4 pathway in acral melanoma indicate the potential for CDK4\/6 inhibitors in targeted therapy","volume":"23","author":"Kong","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.compbiomed.2023.106602_bib56","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.3390\/cancers12102739","article-title":"Role of POT1 in human cancer","volume":"12","author":"Wu","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.compbiomed.2023.106602_bib57","first-page":"210","article-title":"Update in genetic susceptibility in melanoma","volume":"3","author":"Potrony","year":"2015","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.compbiomed.2023.106602_bib58","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1038\/s41388-020-1181-z","article-title":"SLC34A2 simultaneously promotes papillary thyroid carcinoma growth and invasion through distinct mechanisms","volume":"39","author":"He","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.compbiomed.2023.106602_bib59","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41586-018-0792-9","article-title":"Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial","volume":"565","author":"Keskin","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.compbiomed.2023.106602_bib60","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.2147\/OTT.S201799","article-title":"Progression of the role of CRYAB in signaling pathways and cancers","volume":"12","author":"Zhang","year":"2019","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.compbiomed.2023.106602_bib61","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.3390\/cancers12071816","article-title":"Characterization of Class-3 Semaphorin Receptors, Neuropilins and Plexins, as Therapeutic Targets in a Pan-Cancer Study","volume":"vol. 12","author":"Zhang","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.compbiomed.2023.106602_bib62","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1124\/pr.109.001461","article-title":"Pharmacogenomic discovery using cell-based models","volume":"61","author":"Welsh","year":"2009","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.compbiomed.2023.106602_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191264","article-title":"17-AAG inhibits vemurafenib-associated MAP kinase activation and is synergistic with cellular immunotherapy in a murine melanoma model","volume":"13","author":"Joshi","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.compbiomed.2023.106602_bib64","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/cncr.21611","article-title":"Combination of paclitaxel and carboplatin as second-line therapy for patients with metastatic melanoma","volume":"106","author":"Rao","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.compbiomed.2023.106602_bib65","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00280-014-2501-1","article-title":"Treatment of resistant metastatic melanoma using sequential epigenetic therapy (decitabine and panobinostat) combined with chemotherapy (temozolomide)","volume":"74","author":"Xia","year":"2014","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.compbiomed.2023.106602_bib66","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.annonc.2020.05.031","article-title":"Anti-PD1 checkpoint inhibitor therapy in acral melanoma: a multicenter study of 193 Japanese patients","volume":"31","author":"Nakamura","year":"2020","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.compbiomed.2023.106602_bib67","doi-asserted-by":"crossref","first-page":"bbac040","DOI":"10.1093\/bib\/bbac040","article-title":"POSREG: proteomic signature discovered by simultaneously optimizing its reproducibility and generalizability","volume":"23","author":"Li","year":"2022","journal-title":"Briefings Bioinf"},{"key":"10.1016\/j.compbiomed.2023.106602_bib68","article-title":"MMEASE: online meta-analysis of metabolomic data by enhanced metabolite annotation, marker selection and enrichment analysis","volume":"232","author":"Yang","year":"2021","journal-title":"J. Proteonomics"},{"key":"10.1016\/j.compbiomed.2023.106602_bib69","doi-asserted-by":"crossref","first-page":"bbab138","DOI":"10.1093\/bib\/bbab138","article-title":"Pharmacometabonomics: data processing and statistical analysis","volume":"22","author":"Fu","year":"2021","journal-title":"Briefings Bioinf"}],"container-title":["Computers in Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482523000677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482523000677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,2,26]],"date-time":"2023-02-26T20:19:49Z","timestamp":1677442789000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010482523000677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":69,"alternative-id":["S0010482523000677"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiomed.2023.106602","relation":{},"ISSN":["0010-4825"],"issn-type":[{"type":"print","value":"0010-4825"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oncogenic signaling pathways and hallmarks of cancer in Korean patients with acral melanoma","name":"articletitle","label":"Article Title"},{"value":"Computers in Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiomed.2023.106602","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106602"}}